EUVIMEDFaigh amach EUVIMED
CrossrefCárta eolais

Editorial: Are we facing an efficacy–effectiveness gap in pediatric psychopharmacology?

Michael H. Bloch

Journal of Child Psychology and Psychiatry · 2026-12 · 67 (12) · 1933-1936

DOI: 10.1111/jcpp.70252 ↗
AchoimreSonraí leabharliosta

Achoimre

The efficacy–effectiveness gap, the attenuation of benefits as interventions move from controlled trials into routine care, has received substantial focus when scrutinizing psychological interventions but has received less attention in pediatric psychopharmacology. Medication trials evaluate more than molecules: they embed systematic titration, frequent assessment, multi‐informant feedback, and adherence support. This Editorial examines whether differences between trial‐based and routine medication management create a comparable gap. Examples from stimulant treatment in the MTA, antidepressant protocols in TADS and TORDIA, and metabolic surveillance during antipsychotic treatment illustrate how dosing, follow‐up, and safety monitoring may diverge in practice, potentially altering both efficacy and the overall benefit–risk balance. Research should characterize how medications are delivered in routine care and identify which elements of trial‐based management materially improve outcomes. Disseminating evidence‐based pediatric psychopharmacology may require preserving essential medication‐management processes while recognizing constraints faced in practice.

Eolas a oireann do do chuid oibre.

Ó thús saor in aisce agus taighde litríochta pearsanta go dtí an Research Suite iomlán.

Féach ar na taraifí →

An bhfuil gach téacs iomlán ó fhoilsitheoirí san áireamh?

Ní hea. Is ábhair éagsúla iad tagairtí bibleagrafaíocha, achoimrí agus lánthéacsanna. Braitheann fáil an lánthéacs ar an bhfoinse, Open Access agus ar na ceadúnais atá agat cheana. Ní chuireann taraif EUVIMED cearta breise foilsitheora ina n-ionad.

Féach ar na taraifí →